4
Changes in Ownership
Serina Therapeutics, Inc. Filed Acc 0001708599-25-000097
Chief Scientific Officer sold 4,304 shares at an average $5.18 ($22,284)
- Chief Scientific Officer acquired 4,304 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X05/wk-form4_1755724400.xml…